Source: Health Canada shortage reports · Updated Aug 14, 2026
Some Iohexol products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 20, 2026.
An iodinated contrast agent used to improve the clarity of X-ray and CT scans.
Products affected
1 / 4
In shortage since
Jun 23, 2026
Est. full return
Aug 20, 2026
Reports on file
54
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · since Jun 23, 2026, est. end Aug 20, 2026 · Production Delay
Anticipated
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · Production Delay
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 6, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 23, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended May 2, 2025 · Reason for shortage - manufacturing delay
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended Apr 28, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 300
647MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172747 · ended Apr 21, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Mar 3, 2025 · Reason for shortage: production release delay.
A substitute of same concentration but at a different volume will be offered as an alternative.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 27, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 20, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 11, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 3, 2024 · Demand increase for the drug.
Showing 12 of 54 reports. All reports are on file with Health Canada.
What's happening
Iohexol is currently affected by an active shortage report filed with Health Canada by GE HEALTHCARE CANADA INC.
The reported cause is: production delay. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Iohexol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).
Recent changes
Aug 14, 2026
Estimated end date pushed back : Aug 14, 2026 → Aug 20, 2026
Aug 7, 2026
Status changed
Aug 7, 2026
Estimated end date pushed back : Aug 10, 2026 → Aug 14, 2026
Aug 5, 2026
New report filed
Common questions
What is Iohexol used for?
An iodinated contrast agent used to improve the clarity of X-ray and CT scans.
When will Iohexol be back in stock in Canada?
The latest manufacturer estimate is Aug 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Iohexol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.